Novavax, Inc a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the worlds largest vaccine manufacturer by volume, announced that the Drugs Controller General of India has granted emergency use authorization (EUA) for Novavax protein-based COVID-19 vaccine for adolescents aged ≥12 to <18 years in India.
- Read more about Novavax gets DCGI approval for 12 year olds
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/novavax-gets-dcgi-approval-for-12-year-olds
No comments:
Post a Comment